AAAAAA

   
Results: 1-9 |
Results: 9

Authors: PRESS OW SHAN D HOWELLCLARK J EARY J APPELBAUM FR MATTHEWS D KING DJ HAINES AMR HAMANN P HINMAN L SHOCHAT D BERNSTEIN ID
Citation: Ow. Press et al., COMPARATIVE METABOLISM AND RETENTION OF I-125, Y-90, AND IN-111 RADIOIMMUNOCONJUGATES BY CANCER-CELLS, Cancer research, 56(9), 1996, pp. 2123-2129

Authors: ANTONIW P FARNSWORTH APH TURNER A HAINES AMR MOUNTAIN A MACKINTOSH J SHOCHAT D HUMM J WELT S OLD LJ YARRANTON GT KING DJ
Citation: P. Antoniw et al., RADIOIMMUNOTHERAPY OF COLORECTAL-CARCINOMA XENOGRAFTS IN NUDE-MICE WITH Y-90 A33 IGG AND TRI-FAB (TFM), British Journal of Cancer, 74(4), 1996, pp. 513-524

Authors: OBOYLE KP COLLETTI D MAZUREK C WANG Y RAY SK DIAMOND B ROSENBLUM MG EPSTEIN AL SHOCHAT D DUTCHER JP WIERNIK PH KLEIN RS
Citation: Kp. Oboyle et al., POTENTIATION OF ANTIPROLIFERATIVE EFFECTS OF MONOCLONAL-ANTIBODY LYM-1 AND IMMUNOCONJUGATE LYM-1-GELONIN ON HUMAN BURKITTS-LYMPHOMA CELLS WITH GAMMA-INTERFERON AND TUMOR-NECROSIS-FACTOR, Journal of immunotherapy with emphasis on tumor immunology, 18(4), 1995, pp. 221-230

Authors: KOSTERINK JGW DEJONGE MWA SMIT EF PIERS DA KENGEN RAM POSTMUS PE SHOCHAT D GROEN HJM THE HT DELEIJ L
Citation: Jgw. Kosterink et al., PHARMACOKINETICS AND SCINTIGRAPHY OF INDIUM-111-DTPA-MOC-31 IN SMALL-CELL LUNG-CARCINOMA, The Journal of nuclear medicine, 36(12), 1995, pp. 2356-2362

Authors: KING DJ ANTONIW P OWENS RJ ADAIR JR HAINES AMR FARNSWORTH APH FINNEY H LAWSON ADG LYONS A BAKER TS BALDOCK D MACKINTOSH J GOFTON C YARRANTON GT MCWILLIAMS W SHOCHAT D LEICHNER PK WELT S OLD LJ MOUNTAIN A
Citation: Dj. King et al., PREPARATION AND PRECLINICAL EVALUATION OF HUMANIZED A33 IMMUNOCONJUGATES FOR RADIOIMMUNOTHERAPY, British Journal of Cancer, 72(6), 1995, pp. 1364-1372

Authors: BEELEY NRA TURNER A BOYCE BA ANTONIW P FARNSWORTH A HAINES A KING DJ LOW D MOUNTAIN A MILLAR K MILLICAN TA RHIND SK SHOCHAT D ADAIR J YARRANTON GT
Citation: Nra. Beeley et al., IMPROVED PHARMACOKINETICS OF Y-90 DELIVERY WITH MULTIVALENT FAB' FRAGMENTS, The Journal of nuclear medicine, 35(5), 1994, pp. 160000063-160000063

Authors: KING DJ TURNER A FARNSWORTH APH ADAIR JR OWENS RJ PEDLEY RB BALDOCK D PROUDFOOT KA LAWSON ADG BEELEY NRA MILLAR K MILLICAN TA BOYCE BA ANTONIW P MOUNTAIN A BEGENT RHJ SHOCHAT D YARRANTON GT
Citation: Dj. King et al., IMPROVED TUMOR TARGETING WITH CHEMICALLY CROSS-LINKED RECOMBINANT ANTIBODY FRAGMENTS, Cancer research, 54(23), 1994, pp. 6176-6185

Authors: KUZEL T ROSEN ST ZIMMER AM SILVERSTEIN EA SPIES S SALETAN SL NORVITCH ME BIRKHOFER M SHOCHAT D LOBUGLIO AF MEREDITH R KHAZAELI MB POLANSKY A HU E CHEN D LEE K WATKINS K
Citation: T. Kuzel et al., A PHASE-I ESCALATING-DOSE SAFETY, DOSIMETRY AND EFFICACY STUDY OF RADIOLABELED MONOCLONAL-ANTIBODY LYM-1, Cancer biotherapy, 8(1), 1993, pp. 3-16

Authors: MEREDITH R KHAZAELI MB PLOTT G WHEELER R RUSSELL C SHOCHAT D NORVITCH M SALETAN S LOBUGLIO A
Citation: R. Meredith et al., COMPARISON OF DIAGNOSTIC AND THERAPEUTIC DOSES OF I-131 LYM-1 IN PATIENTS WITH NON-HODGKINS-LYMPHOMA, Antibody immunoconjugates, and radiopharmaceuticals, 6(1), 1993, pp. 1-11
Risultati: 1-9 |